The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study.
The authors carried out a door-to-door survey to determine the prevalence of epilepsy among 55,000 people in China. The lifetime prevalence was 7.0/1000, and 41% of all persons had never received appropriate treatment. The prevalence of active epilepsy was 4.6/1000, and 63% of people with active epilepsy had not received antiepileptic treatment in the week before the survey. Figures for the prevalence and the treatment gap were significantly higher than previous estimates.
Wang
W Z
WZ
Department of Neuroepidemiology, Beijing Neurosurgical Institute, PRC. qgnfbwwz@public.bta.net.cn
Wu
J Z
JZ
Wang
D S
DS
Dai
X Y
XY
Yang
B
B
Wang
T P
TP
Yuan
C L
CL
Scott
R A
RA
Prilipko
L L
LL
de Boer
H M
HM
Sander
J W
JW
D000927:Anticonvulsants / Q000627:therapeutic use; D002681:China / Q000453:epidemiology; D004363:Drug Utilization / Q000706:statistics & numerical data; D004827:Epilepsy / Q000188:drug therapy / Q000453:epidemiology*; D006306:Health Surveys; D006801:Humans; D015995:Prevalence; D012494:Sampling Studies; D014944:World Health Organization
D000927:Anticonvulsants